Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

NCT06080061 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06080061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06080061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Recruiting
Start date
October 25, 2023
Completion date
December 31, 2026
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer